Facing a prostate cancer diagnosis can feel overwhelming with an overload of information online. We created several 🆓 prostate cancer patient guides to help you navigate this journey.

They're a must-read for patients & loved ones alike & they are FREE: pcf.org/guide/

Exciting updates from the 2024 PSMA conference - UCSF/UCLA/PCF/Urotoday! Amar Kishan sheds light on MDT for oligometastatic #ProstateCancer . He underscores the crucial role of PSMA PET imaging in patient selection and advocates for further research > bit.ly/3uQYpF5 UC San Francisco UCLA Prostate Cancer Foundation

Accelerating Innovation in Prostate Cancer Research! 🔬

The projects of the PCF Challenge Award recipients underwent rigorous peer review, evaluating scientific merit and potential impact on patients' lives.

Learn more about the work we fund: tinyurl.com/mry9295u

Dr. Alicia Morgans, MD, MPH sits down with Dr. Ben Lowentritt to dive deep into comprehensive care for #prostatecancer patients, especially those with de novo metastatic hormone-sensitive (mHSPC) disease on UroToday.com.

Full interview: tinyurl.com/r2x4vjs8

Sometimes the most impactful prostate cancer messaging comes in settings where men feel most comfortable. Dr. Stanley Frencher of MLK Community Healthcare explains why barbershops, churches, and bodegas are great places to have these important conversations.

More - pcf.org/knowyourrisk/

For men newly diagnosed with metastatic hormone-sensitive prostate cancer, a staggering 60% of deaths occur within just 2 years. Early treatment can be a game-changer for extending lives.

Zach Klaassen discusses this topic in depth: tinyurl.com/5yr76d68

Prostate cancer often requires a multidisciplinary approach involving different specialists at various stages. Benjamin Garmezy discusses the importance of effective communication between urologists and oncologists for the betterment of the patient on UroToday.com

bit.ly/3wtkz15

🚨Decipher & surveillance for #prostatecancer 🚨

👉New data from the ENACT trial suggest Decipher scores might help predict disease progression for patients on active surveillance

JCO Precision Oncology

🔗tinyurl.com/mpuwy8pe

Edward Schaeffer NM Urology Elai Davicioni Prostate Cancer Foundation

New imaging modalities like PSMA PET scans are game-changers for catching metastases traditional scans may miss. Zach Klaassen and Dr. Vahan Kassabian discuss how this technology has led to evolving treatment strategies on UroToday.com

Learn more - bit.ly/4buRp0f

Congratulations to Dr. Lang Josh Lang on this incredible and well deserved achievement!!! 🎉🎉🎉🥳🥳🥳👏👏👏

Study reveals African ancestry gene variant is strongly linked to highly aggressive forms of #ProstateCancer . Mayuko Kanayama, MD, PhD The Johns Hopkins Brady Urological Institute joins Andrea Miyahira Prostate Cancer Foundation to discuss her team's research on a HOXB13 variant in this discussion > bit.ly/41SELF0

Family history can double your risk of #prostatecancer . Screening starts with a simple blood test. Know your Risk. #ItsYourLIfe

Download our free prostate cancer patient guides and learn more- pcf.org/guide/

PSMA PET selection of patients for PSMA radiopharmaceutical therapy. Presentation by Jeremie Calais @ucla discussing the crucial role of PSMA PET at the 2024 PSMA conference - UCSF/UCLA/PCF/Urotoday. #WatchNow on UroToday > bit.ly/43uVS0x UC San Francisco Prostate Cancer Foundation

Powerful results from a survey of partners reported at #EAU24 shed light on an often overlooked issue - the profound effect #prostatecancer has on patients' partners and spouses.

What are your thoughts on this important topic?

Exciting new data from #EAU24 on treatment for mCRPC patients:

The combination of a PARP inhibitor + an androgen receptor signaling inhibitor is showing efficacy as an initial treatment approach, especially for those with BRCA1 or BRCA2 mutations.

tinyurl.com/5yr76d68

Exciting insights from the 2024 UC San Francisco UCLA PSMA conference - UCSF/UCLA/PCF/Urotoday! Michael Morris Memorial Sloan Kettering Cancer Center emphasized the pivotal role of PSMA PET in #ProstateCancer mgmt, navigating its regulatory journey and challenges in interpretation. #WatchNow > bit.ly/3wduQhk Prostate Cancer Foundation

If you attended #AUA24 this year, what was the most significant clinical insight or research update that resonated with you from the conference?

Navigating prostate cancer requires a strong team. Medical oncologist Alicia Morgans, MD, MPH at Dana-Farber, is hosting a discussion with her team on Monday, May 20 at 7:30pm ET to discuss medications, side effects, financial help, and more.

Register here: bit.ly/3UwArrB

For men with high-risk localized #prostatecancer , a new trial examined giving hormone therapy before surgery.

Watch the video to hear Zach Klaassen discuss the results: tinyurl.com/5yr76d68

Phase II study of neoadjuvant Lu-177-PSMA-617 in patients with high-risk localized #ProstateCancer undergoing radical prostatectomy #PRELUDE Trial. Presentation by Nitin Yerram, MD Hackensack Meridian. #AUA24 written coverage by Rashid K. Sayyid University of Toronto > bit.ly/3ybooIU